SMARCB1 and neoplasm: To investigate the tumor suppressor function of the R377H variant in vitro, we used an inducible SMARCB1 re-expression system, which has previously been shown to inhibit cell proliferation when SMARCB1 is re-expressed in SMARCB1-deficient cancer cell lines19.